The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing

Neuroscience

Volumn 193, Issue , 2011, Pages 21-33

  Seif, T ^a   Makriyannis, A ^b   Kunos, G ^c   Bonci, A ^a   Hopf, F W ^a  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Cannabinoid receptors; Dopamine receptors; Drug addiction; Endocannabinoid; Nucleus accumbens

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ACYLGLYCEROL LIPASE; ANANDAMIDE; CANNABINOID 1 RECEPTOR ANTAGONIST; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; ENDOCANNABINOID; FATTY ACID AMIDASE; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; PHOSPHOLIPASE C; QUINPIROLE; RIMONABANT;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL ACTIVITY; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SEEKING BEHAVIOR; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID SYNTHESIS; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIPID HYDROLYSIS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; RECEPTOR UPREGULATION; SPIKE WAVE; WHOLE CELL;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE AGENTS; DRUG INTERACTIONS; ENZYME INHIBITORS; GLYCERIDES; MALE; NEURONS; NUCLEUS ACCUMBENS; PATCH-CLAMP TECHNIQUES; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, METABOTROPIC GLUTAMATE; TIME FACTORS; TYPE C PHOSPHOLIPASES;

EID: 80052447533     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.07.055     Document Type: Article

References (114)

1. Adermark L., Lovinger D.M. Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step. Proc Natl Acad Sci U S A 2007, 104:20564-20569.
2. Alvarez-Jaimes L., Polis I., Parsons L.H. Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala. Neuropsychopharmacology 2008, 33:2483-2493.
3. Ango F., Prézeau L., Muller T., Tu J.C., Xiao B., Worley P.F., Pin J.P., Bockaert J., Fagni L. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature 2001, 411:962-965.
4. Ariano M.A., Stromski C.J., Smyk-Randall E.M., Sibley D.R. D2 dopamine receptor localization on striatonigral neurons. Neurosci Lett 1992, 144:215-220.
5. Azizi P., Haghparast A., Hassanpour-Ezatti M. Effects of CB1 receptor antagonist within the nucleus accumbens on the acquisition and expression of morphine-induced conditioned place preference in morphine-sensitized rats. Behav Brain Res 2009, 197:119-124.
6. Bachtell R.K., Whisler K., Karanian D., Self D.W. Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat. Psychopharmacology (Berl) 2005, 183:41-53.
7. Bari A.A., Pierce R.C. D1-like and D2 dopamine receptor antagonists administered into the shell subregion of the rat nucleus accumbens decrease cocaine, but not food, reinforcement. Neuroscience 2005, 135:959-968.
8. Besheer J., Grondin J.J., Cannady R., Sharko A.C., Faccidomo S., Hodge C.W. Metabotropic glutamate receptor 5 activity in the nucleus accumbens is required for the maintenance of ethanol self-administration in a rat genetic model of high alcohol intake. Biol Psychiatry 2010, 67:812-822.
9. Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A., Matias I., Schiano-Moriello A., Paul P., Williams E.J., Gangadharan U., Hobbs C., Di Marzo V., Doherty P. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 2003, 163:463-468.
10. Bonsi P., Platania P., Martella G., Madeo G., Vita D., Tassone A., Bernardi G., Pisani A. Distinct roles of group I mGlu receptors in striatal function. Neuropharmacology 2008, 55:392-395.
11. Bossert J.M., Poles G.C., Wihbey K.A., Koya E., Shaham Y. Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues. J Neurosci 2007, 27:12655-12663.
12. Bowers M.S., Hopf F.W., Chou J.K., Guillory A.M., Chang S.-J., Janak P.H., Bonci A., Diamond I.F. Nucleus accumbens AGS3 expression drives ethanol seeking through Gβγ. Proc Natl Acad Sci U S A 2008, 105:12533-12538.
13. Bracci E., Centonze D., Bernardi G., Calabresi P. Dopamine excites fast-spiking interneurons in the striatum. J Neurophysiol 2002, 87:2190-2194.
14. Butler A.K., Uryu K., Chesselet M.F. A role for N-methyl-d-aspartate receptors in the regulation of synaptogenesis and expression of the polysialylated form of the neural cell adhesion molecule in the developing striatum. Dev Neurosci 1998, 20:253-262.
15. Caillé S., Alvarez-Jaimes L., Polis I., Stouffer D.G., Parsons L.H. Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. J Neurosci 2007, 27:3695-3702.
16. Centonze D., Rossi S., Prosperetti C., Gasperi V., De Chiara V., Bari M., Tscherter A., Febbraro F., Bernardi G., Maccarrone M. Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons. Mol Cell Neurosci 2007, 35:302-310.
17. Centonze D., Rossi S., Prosperetti C., Tscherter A., Bernardi G., Maccarrone M., Calabresi P. Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. Biol Psychiatry 2005, 57:1583-1589.
18. Cepeda C., André V.M., Yamazaki I., Wu N., Kleiman-Weiner M., Levine M.S. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons. Eur J Neurosci 2008, 27:671-682.
19. Cippitelli A., Cannella N., Braconi S., Duranti A., Tontini A., Bilbao A., Defonseca F.R., Piomelli D., Ciccocioppo R. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. Psychopharmacology (Berl) 2008, 198:449-460.
20. Colwell C.S., Cepeda C., Crawford C., Levine M.S. Postnatal development of glutamate receptor-mediated responses in the neostriatum. Dev Neurosci 1998, 20:154-163.
21. Cravatt B.F., Lichtman A.H. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol 2003, 7:469-475.
22. D'Ascenzo M., Podda M.V., Fellin T., Azzena G.B., Haydon P., Grassi C. Activation of mGluR5 induces spike afterdepolarization and enhanced excitability in medium spiny neurons of the nucleus accumbens by modulating persistent Na+ currents. J Physiol 2009, 587:3233-3250.
23. Deutsch D.G., Chin S.A. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 1993, 46:791-796.
24. Di Chiara G. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res 2002, 137:75-114.
25. Di Ciano P., Robbins T.W., Everitt B.J. Differential effects of nucleus accumbens core, shell, or dorsal striatal inactivations on the persistence, reacquisition, or reinstatement of responding for a drug-paired conditioned reinforcer. Neuropsychopharmacology 2008, 33:1413-1425.
26. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372:686-691.
27. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 2002, 99:10819-10824.
28. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005, 8:1481-1489.
29. Ferré S., Goldberg S.R., Lluis C., Franco R. Looking for the role of cannabinoid receptor heteromers in striatal function. Neuropharmacology 2009, 56(Suppl 1):226-234.
30. Ferretti V., Florian C., Costantini V.J., Roullet P., Rinaldi A., De Leonibus E., Oliverio A., Mele A. Co-activation of glutamate and dopamine receptors within the nucleus accumbens is required for spatial memory consolidation in mice. Psychopharmacology (Berl) 2005, 179:108-116.
31. Flores-Hernández J., Cepeda C., Hernández-Echeagaray E., Calvert C.R., Jokel E.S., Fienberg A.A., Greengard P., Levine M.S. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32. J Neurophysiol 2002, 88:3010-3020.
32. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003, 83:1017-1066.
33. Furuta T., Zhou L., Kaneko T. Preprodynorphin-, preproenkephalin-, preprotachykinin A- and preprotachykinin B-immunoreactive neurons in the accumbens nucleus and olfactory tubercle: double-immunofluorescence analysis. Neuroscience 2002, 114:611-627.
34. Gardner E.L. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav 2005, 81:263-284.
35. Gerdeman G.L., Ronesi J., Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 2002, 5:446-451.
36. Gerfen C.R. Basal ganglia. The rat nervous system 2004, 455-508. Elsevier Academic Press, San Diego, CA. 3rd ed. G. Paxinos (Ed.).
37. Gifford A.N., Ashby C.R. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J Pharmacol Exp Ther 1996, 277:1431-1436.
38. Giuffrida A., Parsons L.H., Kerr T.M., Rodríguez de Fonseca F., Navarro M., Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 1999, 2:358-363.
39. Glass M., Felder C.C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 1997, 17:5327-5333.
40. Godlewski G., Alapafuja S.O., Bátkai S., Nikas S.P., Cinar R., Offertáler L., Osei-Hyiaman D., Liu J., Mukhopadhyay B., Harvey-White J., Tam J., Pacak K., Blankman J.L., Cravatt B.F., Makriyannis A., Kunos G. Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects. Chem Biol 2010, 17:1256-1266.
41. Goto Y., Grace A.A. Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci 2005, 8:805-812.
42. Greengard P., Allen P.B., Nairn A.C. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 1999, 23:435-447.
43. Gubellini P., Picconi B., Bari M., Battista N., Calabresi P., Centonze D., Bernardi G., Finazzi-Agrò A., Maccarrone M. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci 2002, 22:6900-6907.
44. Haluk D.M., Floresco S.B. Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neuropsychopharmacology 2009, 34:2041-2052.
45. Herkenham M. Cannabinoid receptor localization in brain: relationship to motor and reward systems. Ann N Y Acad Sci 1992, 654:19-32.
46. Hiranita T., Nawata Y., Sakimura K., Yamamoto T. Methamphetamine-seeking behavior is due to inhibition of nicotinic cholinergic transmission by activation of cannabinoid CB1 receptors. Neuropharmacology 2008, 55:1300-1306.
47. Hiroi N., White N.M. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res 1991, 552:141-152.
48. Hodge C.W., Samson H.H., Chappelle A.M. Alcohol self-administration: further examination of the role of dopamine receptors in the nucleus accumbens. Alcohol Clin Exp Res 1997, 21:1083-1091.
49. Hoffman A.F., Lupica C.R. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J Neurophysiol 2001, 85:72-83.
50. Hopf F.W., Cascini M.G., Gordon A.S., Diamond I., Bonci A. Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits. J Neurosci 2003, 23:5079-5087.
51. Hopf F.W., Seif T., Mohamedi M.L., Chen B.T., Bonci A. The small-conductance calcium-activated potassium channel is a key modulator of firing and long-term depression in the dorsal striatum. Eur J Neurosci 2010, 31:1946-1959.
52. Howe A.R., Surmeier D.J. Muscarinic receptors modulate N-, P-, and L-type Ca2+ currents in rat striatal neurons through parallel pathways. J Neurosci 1995, 15:458-469.
53. Hu X.T., Dong Y., Zhang X.F., White F.J. Dopamine D2 receptor-activated Ca2+ signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons. J Neurophysiol 2005, 93:1406-1417.
54. Jones E.A., Wang J.Q., McGinty J.F. Intrastriatal GABA(A) receptor blockade does not alter dopamine D(1)/D(2) receptor interactions in the intact rat striatum. Neuroscience 2001, 102:381-389.
55. Jung K.M., Mangieri R., Stapleton C., Kim J., Fegley D., Wallace M., Mackie K., Piomelli D. Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol Pharmacol 2005, 68:1196-1202.
56. Kalivas P.W., McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 2003, 168:44-56.
57. Kawaguchi Y., Wilson C.J., Emson P.C. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci 1990, 10:3421-3438.
58. Kearn C.S., Blake-Palmer K., Daniel E., Mackie K., Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?. Mol Pharmacol 2005, 67:1697-1704.
59. Köfalvi A., Rodrigues R.J., Ledent C., Mackie K., Vizi E.S., Cunha R.A., Sperlágh B. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J Neurosci 2005, 25:2874-2884.
60. Kreitzer A.C., Malenka R.C. Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J Neurosci 2005, 25:10537-10545.
61. Kreitzer A.C., Malenka R.C. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 2007, 445:643-647.
62. Kumaresan V., Yuan M., Yee J., Famous K.R., Anderson S.M., Schmidt H.D., Pierce R.C. Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking. Behav Brain Res 2009, 202:238-244.
63. Le Foll B., Gallo A., Le Strat Y., Lu L., Gorwood P. Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol 2009, 20:1-17.
64. Lévesque M., Parent A. The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies. Proc Natl Acad Sci U S A 2005, 102:11888-11893.
65. Lin J.Y., Chung K.K., de Castro D., Funk G.D., Lipski J. Effects of muscarinic acetylcholine receptor activation on membrane currents and intracellular messengers in medium spiny neurones of the rat striatum. Eur J Neurosci 2004, 20:1219-1230.
66. Long J.Z., Li W., Booker L., Burston J.J., Kinsey S.G., Schlosburg J.E., Pavón F.J., Serrano A.M., Selley D.E., Parsons L.H., Lichtman A.H., Cravatt B.F. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 2009, 5:37-44.
67. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., Gasperi V., Prosperetti C., Bernardi G., Finazzi-Agrò A., Cravatt B.F., Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci 2008, 11:152-159.
68. Mahon S., Delord B., Deniau J.M., Charpier S. Intrinsic properties of rat striatal output neurones and time-dependent facilitation of cortical inputs in vivo. J Physiol 2000, 527(Pt 2):345-354.
69. Malinen H., Hyytiä P. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats. Alcohol Clin Exp Res 2008, 32:1976-1983.
70. Martín A.B., Fernandez-Espejo E., Ferrer B., Gorriti M.A., Bilbao A., Navarro M., Rodriguez de Fonseca F., Moratalla R. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology 2008, 33:1667-1679.
71. McFarland K., Kalivas P.W. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 2001, 21:8655-8663.
72. Meschler J.P., Howlett A.C. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology 2001, 40:918-926.
73. Mitrano D.A., Smith Y. Comparative analysis of the subcellular and subsynaptic localization of mGluR1a and mGluR5 metabotropic glutamate receptors in the shell and core of the nucleus accumbens in rat and monkey. J Comp Neurol 2007, 500:788-806.
74. Morra J.T., Glick S.D., Cheer J.F. Neural encoding of psychomotor activation in the nucleus accumbens core, but not the shell, requires cannabinoid receptor signaling. J Neurosci 2010, 30:5102-5107.
75. Musella A., De Chiara V., Rossi S., Cavasinni F., Castelli M., Cantarella C., Mataluni G., Bernardi G., Centonze D. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. Neuroscience 2010, 167:864-871.
76. Nadjar A., Brotchie J.M., Guigoni C., Li Q., Zhou S.B., Wang G.J., Ravenscroft P., Georges F., Crossman A.R., Bezard E. Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia. J Neurosci 2006, 26:8653-8661.
77. Nakamura M., Sato K., Fukaya M., Araishi K., Aiba A., Kano M., Watanabe M. Signaling complex formation of phospholipase Cbeta4 with metabotropic glutamate receptor type 1alpha and 1,4,5-trisphosphate receptor at the perisynapse and endoplasmic reticulum in the mouse brain. Eur J Neurosci 2004, 20:2929-2944.
78. Narushima M., Uchigashima M., Fukaya M., Matsui M., Manabe T., Hashimoto K., Watanabe M., Kano M. Tonic enhancement of endocannabinoid-mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum. J Neurosci 2007, 27:496-506.
79. Nicola S.M. The nucleus accumbens as part of a basal ganglia action selection circuit. Psychopharmacology (Berl) 2007, 191:521-550.
80. Nicola S.M., Malenka R.C. Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens. J Neurosci 1997, 17:5697-5710.
81. Nicola S.M., Surmeier J., Malenka R.C. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 2000, 23:185-215.
82. Nowend K.L., Arizzi M., Carlson B.B., Salamone J.D. D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption. Pharmacol Biochem Behav 2001, 69:373-382.
83. Orio L., Edwards S., George O., Parsons L.H., Koob G.F. A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions. J Neurosci 2009, 29:4846-4857.
84. Partridge J.G., Tang K.C., Lovinger D.M. Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. J Neurophysiol 2000, 84:1422-1429.
85. Perez M.F., White F.J., Hu X.T. Dopamine D(2) receptor modulation of K(+) channel activity regulates excitability of nucleus accumbens neurons at different membrane potentials. J Neurophysiol 2006, 96:2217-2228.
86. Perreault M.L., Hasbi A., Alijaniaram M., Fan T., Varghese G., Fletcher P.J., Seeman P., O'Dowd B.F., George S.R. The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J Biol Chem 2010, 285:36625-36634.
87. Pezze M.A., Dalley J.W., Robbins T.W. Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task. Neuropsychopharmacology 2007, 32:273-283.
88. Pickel V.M., Chan J., Kearn C.S., Mackie K. Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol 2006, 495:299-313.
89. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003, 4:873-884.
90. Placzek E.A., Okamoto Y., Ueda N., Barker E.L. Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. Neuropharmacology 2008, 55:1095-1104.
91. Podda M.V., Riccardi E., D'Ascenzo M., Azzena G.B., Grassi C. Dopamine D1-like receptor activation depolarizes medium spiny neurons of the mouse nucleus accumbens by inhibiting inwardly rectifying K+ currents through a cAMP-dependent protein kinase A-independent mechanism. Neuroscience 2010, 167:678-690.
92. Reissner K.J., Kalivas P.W. Using glutamate homeostasis as a target for treating addictive disorders. Behav Pharmacol 2010, 21:514-522.
93. Richter A., Löscher W. Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia. Eur J Pharmacol 2002, 454:145-151.
94. Robbe D., Alonso G., Duchamp F., Bockaert J., Manzoni O.J. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci 2001, 21:109-116.
95. Romano C., Sesma M.A., McDonald C.T., O'Malley K., Van den Pol A.N., Olney J.W. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 1995, 355:455-469.
96. Schmidt H.D., Pierce R.C. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat. Neuroscience 2006, 142:451-461.
97. Shigemoto R., Nomura S., Ohishi H., Sugihara H., Nakanishi S., Mizuno N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 1993, 163:53-57.
98. Sidló Z., Reggio P.H., Rice M.E. Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels. Neurochem Int 2008, 52:80-88.
99. Sperlágh B., Windisch K., Andó R.D., Sylvester Vizi E. Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens. Neurochem Int 2009, 54:452-457.
100. Surmeier D.J., Bargas J., Hemmings H.C., Nairn A.C., Greengard P. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 1995, 14:385-397.
101. Surmeier D.J., Ding J., Day M., Wang Z., Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 2007, 30:228-235.
102. Surmeier D.J., Song W.J., Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 1996, 16:6579-6591.
103. Suto N., Ecke L.E., Wise R.A. Control of within-binge cocaine-seeking by dopamine and glutamate in the core of nucleus accumbens. Psychopharmacology (Berl) 2009, 205:431-439.
104. Tepper J.M., Sharpe N.A., Koós T.Z., Trent F. Postnatal development of the rat neostriatum: electrophysiological, light- and electron-microscopic studies. Dev Neurosci 1998, 20:125-145.
105. Tripathi A., Prensa L., Cebrián C., Mengual E. Axonal branching patterns of nucleus accumbens neurons in the rat. J Comp Neurol 2010, 518:4649-4673.
106. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M., Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci 2007, 27:3663-3676.
107. Uchimura N., North R.A. Actions of cocaine on rat nucleus accumbens neurones in vitro. Br J Pharmacol 1990, 99:736-740.
108. Wang J., Ueda N. Role of the endocannabinoid system in metabolic control. Curr Opin Nephrol Hypertens 2008, 17:1-10.
109. Waszczak B.L., Martin L.P., Greif G.J., Freedman J.E. Expression of a dopamine D2 receptor-activated K+ channel on identified striatopallidal and striatonigral neurons. Proc Natl Acad Sci U S A 1998, 95:11440-11444.
110. Xi Z.X., Gilbert J.G., Peng X.Q., Pak A.C., Li X., Gardner E.L. Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J Neurosci 2006, 26:8531-8536.
111. Yao L., Arolfo M.P., Dohrman D.P., Jiang Z., Fan P., Fuchs S., Janak P.H., Gordon A.S., Diamond I. Betagamma dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell 2002, 109:733-743.
112. Yin H.H., Lovinger D.M. Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc Natl Acad Sci U S A 2006, 103:8251-8256.
113. Zhang X.F., Hu X.T., White F.J. Whole-cell plasticity in cocaine withdrawal: reduced sodium currents in nucleus accumbens neurons. J Neurosci 1998, 18:488-498.
114. Zhou D., Shearman L.P. Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice. Pharmacol Biochem Behav 2004, 77:117-125.